These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1263995)

  • 1. [Treatment of peripheral occlusive vascular disease with pentoxifylin (author's transl)].
    Traumann KJ
    Med Klin; 1976 Mar; 71(11):465-8. PubMed ID: 1263995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Denck H
    Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
    Angelkort B; Doppelfeld E
    Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ophthalmological experiences with the xanthine compound BL 191 (author's transl)].
    Heinsius E; Flamm P
    Med Klin; 1973 Nov; 68(47):1540-8. PubMed ID: 4781096
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A; Rieger H
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)].
    Kellner H
    MMW Munch Med Wochenschr; 1976 Oct; 118(43):1399-1402. PubMed ID: 825745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
    von Westphalen JG
    MMW Munch Med Wochenschr; 1977 Jul; 119(26):901-4. PubMed ID: 408616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases].
    Giansante C; Di Chiara A; Fiotti N; Mauri F; Sorrentino A; Spanghero M; Tomasin L; Calabrese S
    Clin Ter; 1990 Sep; 134(5):301-5. PubMed ID: 2149312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the treatment of acute arterial circulatory disturbances of the retina and optic nerve (author's transl)].
    Küchle HJ
    Klin Monbl Augenheilkd; 1977 Sep; 171(3):395-406. PubMed ID: 336975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
    Ratschow R
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1131-4. PubMed ID: 823407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.
    Spitzer S; Bach R; Schieffer H
    Int Angiol; 1992; 11(3):204-10. PubMed ID: 1460355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
    Schweiger H; Ortmeier CJ
    Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of arterial diseases. A study with Trental 400].
    Tannenberg G
    Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification].
    Branchereau A; Rouffy J
    J Mal Vasc; 1995; 20(1):21-7. PubMed ID: 7745355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of PGE-1 in patients suffering from peripheral arterial occlusive disease.
    Milio G; Cospite V; Cospite M
    Minerva Cardioangiol; 2003 Jun; 51(3):311-6. PubMed ID: 12867883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced improvement of blood flow properties. Effective principle in the treatment of arterial occlusive diseases].
    Hess H; Franke I; Jauch M
    Fortschr Med; 1973 Jun; 91(17):743-8. PubMed ID: 4577522
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peripheral macro-and microcirculatory changes in acute arterial obstruction with papaverine and trental administration].
    Koshkin VM; Adil'khanov SG; Antonova NIu
    Vestn Khir Im I I Grek; 1979 Dec; 123(12):56-60. PubMed ID: 524688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.